Invention Grant
- Patent Title: Arylpiperazine derivatives and methods of utilizing same
-
Application No.: US15018174Application Date: 2016-02-08
-
Publication No.: US09604944B2Publication Date: 2017-03-28
- Inventor: Laxminarayan Bhat , Prabhu Prasad Mohapatra , Kouacou Adiey
- Applicant: REVIVA PHARMACEUTICALS, INC.
- Applicant Address: US CA Santa Clara
- Assignee: REVIVA PHARMACEUTICALS, INC.
- Current Assignee: REVIVA PHARMACEUTICALS, INC.
- Current Assignee Address: US CA Santa Clara
- Agency: Perkins Coie LLP
- Agent Viola T. Kung
- Main IPC: C07D413/12
- IPC: C07D413/12 ; C07D417/12 ; C07D265/36 ; A61K31/538
Abstract:
The present invention provides arylpiperazine derivatives having Formula 1a as shown below, which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression,
Public/Granted literature
- US20160229821A1 ARYLPIPERAZINE DERIVATIVES AND METHODS OF UTILIZING SAME Public/Granted day:2016-08-11
Information query
